Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Careers Booklet

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 June 1989:
Vol. 244. no. 4910, pp. 1357 - 1360
DOI: 10.1126/science.2786647
Prev | Table of Contents | Next

Articles

Science, Vol 244, Issue 4910, 1357-1360
Copyright © 1989 by American Association for the Advancement of Science

articles

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

J Homsy, M Meyer, M Tateno, S Clarkson, and JA Levy

Department of Medicine, School of Medicine, University of California, San Francisco 94143.

Antibodies that enhance human immunodeficiency virus (HIV) infectivity have been found in the blood of infected individuals and in infected or immunized animals. These findings raise serious concern for the development of a safe vaccine against acquired immunodeficiency syndrome. To address the in vivo relevance and mechanism of this phenomenon, antibody-dependent enhancement of HIV infectivity in peripheral blood macrophages, lymphocytes, and human fibroblastoid cells was studied. Neither Leu3a, a monoclonal antibody directed against the CD4 receptor, nor soluble recombinant CD4 even at high concentrations prevented this enhancement. The addition of monoclonal antibody to the Fc receptor III (anti-FcRIII), but not of antibodies that react with FcRI or FcRII, inhibited HIV type 1 and HIV type 2 enhancement in peripheral blood macrophages. Although enhancement of HIV infection in CD4+ lymphocytes could not be blocked by anti-FcRIII, it was inhibited by the addition of human immunoglobulin G aggregates. The results indicate that the FcRIII receptor on human macrophages and possibly another Fc receptor on human CD4+ lymphocytes mediate antibody-dependent enhancement of HIV infectivity and that this phenomenon proceeds through a mechanism independent of the CD4 protein.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Effector Memory {alpha}{beta} T Lymphocytes Can Express Fc{gamma}RIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity.
B. Clemenceau, R. Vivien, M. Berthome, N. Robillard, R. Garand, G. Gallot, S. Vollant, and H. Vie (2008)
J. Immunol. 180, 5327-5334
   Abstract »    Full Text »    PDF »
Role of Anti-Glycoproteins D (Anti-gD) and K (Anti-gK) IgGs in Pathology of Herpes Stromal Keratitis in Humans.
K. R. Mott, Y. Osorio, E. Maguen, A. B. Nesburn, A. E. Wittek, S. Cai, S. Chattopadhyay, and H. Ghiasi (2007)
Invest. Ophthalmol. Vis. Sci. 48, 2185-2193
   Abstract »    Full Text »    PDF »
The Engagement of Activating Fc{gamma}Rs Inhibits Primate Lentivirus Replication in Human Macrophages.
A. David, A. Saez-Cirion, P. Versmisse, O. Malbec, B. Iannascoli, F. Herschke, M. Lucas, F. Barre-Sinoussi, J.-F. Mouscadet, M. Daeron, et al. (2006)
J. Immunol. 177, 6291-6300
   Abstract »    Full Text »    PDF »
HIV Pathogenesis: Knowledge Gained after Two Decades of Research.
J.A. Levy (2006)
Adv. Dent. Res. 19, 10-16
   Abstract »    Full Text »    PDF »
Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
S. Broche-Pierre, J. Richardson, A. Moraillon, and P. Sonigo (2005)
J. Gen. Virol. 86, 2495-2506
   Abstract »    Full Text »    PDF »
Antibody-mediated growth of infectious salmon anaemia virus in macrophage-like fish cell lines.
T. Joseph, M. T. Kibenge, and F. S. B. Kibenge (2003)
J. Gen. Virol. 84, 1701-1710
   Abstract »    Full Text »    PDF »
Fc{gamma} Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages.
D. Perez-Bercoff, A. David, H. Sudry, F. Barre-Sinoussi, and G. Pancino (2003)
J. Virol. 77, 4081-4094
   Abstract »    Full Text »    PDF »
Lymphoid activation: a confounding factor in AIDS vaccine development?.
J. Richardson, S. Broche, S. Baud, T. Leste-Lasserre, F. Femenia, D. Levy, A. Moraillon, G. Pancino, and P. Sonigo (2002)
J. Gen. Virol. 83, 2515-2521
   Abstract »    Full Text »    PDF »
Comparison of Human Immunodeficiency Virus (HIV)-Specific Infection-Enhancing and -Inhibiting Antibodies in AIDS Patients.
R. A. Subbramanian, J. Xu, E. Toma, R. Morisset, E. A. Cohen, J. Menezes,, and A. Ahmad (2002)
J. Clin. Microbiol. 40, 2141-2146
   Abstract »    Full Text »    PDF »
Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain.
J. Girn, M. Kavoosi, and J. Chantler (2002)
J. Gen. Virol. 83, 351-358
   Abstract »    Full Text »    PDF »
Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1.
H. Bouhlal, J. Galon, M. D. Kazatchkine, W.-H. Fridman, C. Sautes-Fridman, and N. Haeffner Cavaillon (2001)
J. Immunol. 166, 3377-3383
   Abstract »    Full Text »    PDF »
CD95 (Fas) Ligand-Expressing Vesicles Display Antibody-Mediated, FcR-Dependent Enhancement of Cytotoxicity.
S. Jodo, A. M. Hohlbaum, S. Xiao, D. Chan, D. Strehlow, D. H. Sherr, A. Marshak-Rothstein, and S.-T. Ju (2000)
J. Immunol. 165, 5487-5494
   Abstract »    Full Text »    PDF »
Bioactivities of Fas Ligand-Expressing Retroviral Particles.
S. Jodo, D. Strehlow, and S.-T. Ju (2000)
J. Immunol. 164, 5062-5069
   Abstract »    Full Text »    PDF »
An Envelope Modification That Renders a Primary, Neutralization-Resistant Clade B Human Immunodeficiency Virus Type 1 Isolate Highly Susceptible to Neutralization by Sera from Other Clades.
L. Stamatatos and C. Cheng-Mayer (1998)
J. Virol. 72, 7840-7845
   Abstract »    Full Text »    PDF »
Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1.
V. Marechal, F. Clavel, J. M. Heard, and O. Schwartz (1998)
J. Virol. 72, 2208-2212
   Abstract »    Full Text »    PDF »
Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice.
P. Seiler, U. Kalinke, T. Rulicke, E. M. Bucher, C. Bose, R. M. Zinkernagel, and H. Hengartner (1998)
J. Virol. 72, 2253-2258
   Abstract »    Full Text »    PDF »
Candidate AIDS Vaccines.
B. S. Graham and P. F. Wright (1995)
N. Engl. J. Med. 333, 1331-1339
   Full Text »    PDF »
Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.
J. Sixbey and Q. Yao (1992)
Science 255, 1578-1580
   Abstract »    PDF »
Vaccination for disease.
S Oehen, H Hengartner, and R. Zinkernagel (1991)
Science 251, 195-198
   Abstract »    PDF »
Human CD4 binds immunoglobulins.
P Lenert, D Kroon, H Spiegelberg, E. Golub, and M Zanetti (1990)
Science 248, 1639-1643
   Abstract »    PDF »
The basic defect in cystic fibrosis.
I. Levitan (1989)
Science 244, 1423
   PDF »
The Human Low Affinity Fcgamma Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties.
K. Maenaka, P. A. van der Merwe, D. I. Stuart, E. Y. Jones, and P. Sondermann (2001)
J. Biol. Chem. 276, 44898-44904
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)